3812 results for «2024»
3812 results
Major Late-Breaking Trials from EuroPCR 2024
15 May 2024 – From EuroPCR 2024
This session presents the latest results from major late-breaking trials presented at EuroPCR 2024. It covers a one-month DAPT followed by 5-month ticagrelor monotherapy in acute coronary syndromes with DCB, the first TAVI vs. SAVR randomised trial in younger low-risk patients with severe tricuspid or bicuspid...
TAVI innovations: latest breakthroughs from PCR London Valves 2024
24 Nov 2024 – From PCR London Valves 2024
Curious about the latest advancements shaping the future of TAVI? Don't miss this video which deliver insights from the PCR London Valves 2024 Late-Breaking Trials, diving into key topics that matter most in clinical practice.
Explore 5-year outcomes of AVR in low-risk patients stratified by annulus size,...
Most impactful trials in structural heart disease 2024/2025
30 Sep 2025 – From PCR Gulf Valves 2025
Delve into the most impactful structural heart disease trials shaping 2024 and 2025. This session addresses current dilemmas in TAVI, including early intervention and management of small annuli, evaluates evidence for transcatheter mitral and tricuspid valve repair, and identifies evidence gaps relevant to the region, providing...
Aortic valve: PCR London Valves 2024 highlights
26 Nov 2024 – From PCR London Valves 2024
Chris Cook interviews Hélène Eltchaninoff and Bernard Prendergast to discuss the highlights of PCR London Valves 2024, focusing on aortic valve disease. They explore how groundbreaking research, including the EARLY TAVR and COMPARE TAVI trials, is shaping and transforming clinical practice.
This interview was filmed at PCR...
Interventions for valvular disease: Highlights of EuroPCR 2024
16 May 2024 – From EuroPCR 2024
Christopher Cook hosts Nicolas Dumonteil and Bernard Prendergast as they share EuroPCR 2024 insights on valve disease interventions. Nicolas Dumonteil highlights record-breaking abstracts and cases, demonstrating expertise in TAVI, mitral, and tricuspid procedures. Bernard Prendergast emphasizes LIVE cases, especially in complex TAVI scenarios, reflecting everyday practice. Both stress...
New York Valves 2024: Everything you need to know in a nutshell
11 Jun 2024
Alex Sticchi provides his take on the trials which were presented at New York Valves 2024, offering a concise summary, a short description and final thoughts.
Author
Contemporary treatment for Small Aortic Annuli in 2024
25 Nov 2024 – From PCR London Valves 2024
In this roundtable discussion, Gunasekaran Sengottuvelu, Viveka Kumar, and Haresh Mehta explore optimal treatment strategies and the selection of valve types for challenging anatomies such as small annuli—a condition prevalent in a significant portion of the Indian population.
This interview was filmed at PCR London Valves 2024:...
Mitral valve: PCR London Valves 2024 highlights
26 Nov 2024 – From PCR London Valves 2024
Chiara De Biase interviews Sam Dawkins and Francesco Maisano about the PCR London Valves 2024 highlights on mitral valve disease. They highlight sessions analyzing the latest trial evidence, including the two-year data from the MiCLASP and CLASP IID studies. The Congress also stands out for its...
Best of science and education in cardiovascular interventional medicine in 2024
16 Dec 2024
Dear Colleagues, dear PCR Companions,
As we welcome a new year, it is the perfect time to reflect on what we achieved together over the past year—both as a celebration of our successes and as motivation to continue improving in the year ahead.
2024 was a record year...
Perspectives on drug coated balloons from EuroPCR 2024
16 May 2024 – From EuroPCR 2024
In this roundtable discussion, Azeem Latib and Antonio Colombo discuss the role of drug-coated balloons (DCBs) in their current practice, including their indications, the different types of DCBs, and how to choose between them. They also cover ongoing studies in the US aimed at bringing this...
Innovations in cardiovascular interventions for chronic heart failure: where are we in 2024?
15 May 2024 – From EuroPCR 2024
Is there an ongoing need for interventions in chronic heart failure? At ACC, a significant trial unveiled interatrial shunting. What does this mean for patients? Explore the devices involved in neuromodulation and considerations for patient discussions. Who might benefit from intravascular monitoring? Watch Giuseppe Rosano and...
Tricuspid valve disease: PCR London Valves 2024 highlights
26 Nov 2024 – From PCR London Valves 2024
Nicolo Piazza and Fabien Praz join Christopher Cook to highlight the key takeaways from the latest presentations on the tricuspid valve.They evoke the new research and scientific evidence that will have an impact on clinical practice, the rapidly evolving technical innovations and the challenges facing tricuspid...
EuroPCR 2024 delivered an eye-opening focus on imaging guidance
24 May 2024
A record 12,100 participants from 130 countries have just taken part in the highly educational WorldLeading Course in interventional cardiovascular medicine. They enjoyed a unique opportunity to exchange their knowledge, skills and experience on a global scale.
Paris – France, 17 May 2024. As always, the thought-provoking...
AHA 2024: get the interventional cardiology perspective!
13 Nov 2024
Stay up to date with what is new and hot in interventional cardiology at #AHA24 in Chicago.
Meet the EuroPCR 2024 Andreas Grüntzig Ethica Awardees
16 May 2024
Ottavio Alfieri and Frederick St Goar received the award for their important work on developing new opportunities for expanding indications of interventions targeting mitral regurgitation in patients with heart failure, with benefits including mortality reduction in selected cases. Find out more about the achievements of this...
EuroPCR 2024 – Built by and for its participants, more than ever before
29 Mar 2024
Over 11,000 participants from around the globe are once again expected at EuroPCR – a Course tailored for interventional cardiologists, cardiac surgeons, imaging specialists, radiologists, nurses, allied professionals and other practitioners, as well as researchers, innovators and industry representatives. They will be sharing their knowledge, skills and experience on...
A review of the 2024 ESC Guidelines on elevated blood pressure and hypertension
13 Nov 2024
Lucas Lauder and Felix Mahfoud provide a summary of the ESC Guidelines on elevated blood pressure and hypertension presented by John William McEvoy and Rhian Touyz at ESC Congress 2024 in London.
Author
Author
EuroPCR 2024: Keen to learn and share with your community online?
07 May 2024
Even if you can’t join in person, it’s not too late to sign up for the digital package at the unique fee of 490€ and take advantage of everything it has to offer – during and after the Course!
Apply now for a chance of granting towards participation at EuroPCR 2024
PCR Tokyo Valves 2024: Dive into the Scientific Programme!
